Work

[Efficacy and safety analysis of the OR-CHOP regimen for the treatment of MCD subtype diffuse large B cell lymphoma in the real-world setting].

Year: 2024

Type: other

Abstract: This study revealed that the OR-CHOP regimen can be used as an effective and safe first-line treatment for MCD subtype DLBCL.

Source: PubMed

DOI: 10.3760/cma.j.cn121090-20240607-00212

Authors: H Yin, W Hua, H R Shen, J Z Wu, Y Li, L Wang, J H Liang, J Y Li, W Xu

Institution: Jiangsu Province Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Jiangsu Science and Technology Department

Awards: G3070737083, G4650615677, G5966407935, G825344697, G8552312261, G8883311937

OpenAlex ID: W4403516167

Cites:

Cited by: 1

Related to: 10